Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Apr 2020
Historique:
received: 23 05 2019
revised: 03 07 2019
accepted: 18 07 2019
pubmed: 7 11 2019
medline: 21 10 2020
entrez: 6 11 2019
Statut: ppublish

Résumé

Cryptococcal meningitis causes 15% of AIDS-related deaths. Optimal management and clinical outcomes of pregnant women with cryptococcosis are limited to case reports, as pregnant women are often excluded from research. Amongst pregnant women with asymptomatic cryptococcosis, no treatment guidelines exist. We prospectively identified HIV-infected women who were pregnant or recently pregnant with cryptococcosis, screened during a series of meningitis research studies in Uganda from 2012 to 2018. Among 571 women screened for cryptococcosis, 13 were pregnant, one was breastfeeding, three were within 14 days postpartum, and two had recently miscarried. Of these 19 women (3.3%), 12 had cryptococcal meningitis, six had cryptococcal antigenemia, and one had a history of cryptococcal meningitis and was receiving secondary prophylaxis. All women with meningitis received amphotericin B deoxycholate (0.7-1.0 mg/kg). Five were exposed to 200-800 mg fluconazole during pregnancy. Of these five, three delivered healthy babies with no gross physical abnormalities at birth, one succumbed to meningitis, and one outcome was unknown. Maternal meningitis survival rate at hospital discharge was 75% (9/12), and neonatal/fetal survival rate was 44% (4/9) for those mothers who survived. Miscarriages and stillbirths were common (n = 4). Of six women with cryptococcal antigenemia, two received fluconazole, one received weekly amphotericin B, and three had unknown treatment courses. All women with antigenemia survived, and none developed clinical meningitis. We report good maternal outcomes but poor fetal outcomes for cryptococcal meningitis using amphotericin B, without fluconazole in the first trimester, and weekly amphotericin B in place of fluconazole for cryptococcal antigenemia.

Identifiants

pubmed: 31689712
pii: 5549534
doi: 10.1093/mmy/myz084
pmc: PMC7179752
doi:

Substances chimiques

Antifungal Agents 0
Drug Combinations 0
Deoxycholic Acid 005990WHZZ
Amphotericin B 7XU7A7DROE
amphotericin B, deoxycholate drug combination 87687-70-5
Fluconazole 8VZV102JFY

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

282-292

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS086312
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI138851
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI055433
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : T35 AI118620
Pays : United States
Organisme : FIC NIH HHS
ID : K01 TW010268
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Références

Rev Soc Bras Med Trop. 2006 Sep-Oct;39(5):501-3
pubmed: 17160332
Pharmacotherapy. 1999 Feb;19(2):221-2
pubmed: 10030772
Rev Inst Med Trop Sao Paulo. 1993 Jul-Aug;35(4):367-71
pubmed: 8115798
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):e164-71
pubmed: 25886930
J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr;10(2):79-82
pubmed: 21317164
Pediatr Infect Dis J. 1992 Dec;11(12):1062-4
pubmed: 1461702
N Engl J Med. 2014 Jun 26;370(26):2487-98
pubmed: 24963568
Med Mycol Case Rep. 2017 Oct 28;19:9-12
pubmed: 30148053
JAMA. 2016 Jan 5;315(1):58-67
pubmed: 26746458
J Antimicrob Chemother. 2008 Jul;62(1):172-6
pubmed: 18400803
Lancet Infect Dis. 2011 Dec;11(12):933-41
pubmed: 21982529
J Hum Lact. 2002 May;18(2):168-71
pubmed: 12033079
Congenit Anom (Kyoto). 2019 Mar;59(2):39-42
pubmed: 29653020
BMC Res Notes. 2018 Oct 22;11(1):753
pubmed: 30348201
Semin Perinatol. 1997 Aug;21(4):336-50
pubmed: 9298723
Obstet Gynecol. 2006 Feb;107(2 Pt 2):535-7
pubmed: 16449178
Clin Infect Dis. 2007 Nov 1;45(9):1192-9
pubmed: 17918082
Eur J Clin Pharmacol. 1994;46(2):115-8
pubmed: 8039528
N Engl J Med. 1997 Jul 3;337(1):15-21
pubmed: 9203426
Med Mycol Case Rep. 2014 May 29;5:16-9
pubmed: 24944885
Open Forum Infect Dis. 2015 Apr 02;2(2):ofv046
pubmed: 26213690
Prenat Diagn. 1998 Aug;18(8):862-3
pubmed: 9742580
N Engl J Med. 2016 Feb 11;374(6):542-54
pubmed: 26863355
AIDS. 2012 Jun 1;26(9):1105-13
pubmed: 22421244
Pediatr Infect Dis J. 2004 Mar;23(3):278-9
pubmed: 15014313
Res Commun Chem Pathol Pharmacol. 1993 Mar;79(3):381-4
pubmed: 8480084
Am J Med Genet. 1997 Oct 31;72(3):253-6
pubmed: 9332650
N Engl J Med. 2017 Jul 20;377(3):233-245
pubmed: 28723333
Mycopathologia. 2009 Mar;167(3):125-31
pubmed: 18931938
Trop Med Int Health. 2007 Aug;12(8):929-35
pubmed: 17697087
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189
pubmed: 30399034
Reprod Toxicol. 2001 Jul-Aug;15(4):421-7
pubmed: 11489598
Curr HIV/AIDS Rep. 2015 Mar;12(1):1-5
pubmed: 25620530
Lancet Infect Dis. 2016 Jul;16(7):809-818
pubmed: 26971081
Ann Pharmacother. 1997 Jan;31(1):118-9
pubmed: 8997479
Clin Infect Dis. 1994 Mar;18(3):364-8
pubmed: 8011817
Can J Infect Dis Med Microbiol. 2009 Fall;20(3):e97-9
pubmed: 20808462
Infection. 1996 May-Jun;24(3):263-6
pubmed: 8811369
Medicine (Baltimore). 1998 May;77(3):153-67
pubmed: 9653427
Clin Infect Dis. 2010 Feb 1;50(3):291-322
pubmed: 20047480
Birth Defects Res A Clin Mol Teratol. 2005 Nov;73(11):919-23
pubmed: 16265639
Pediatr Res. 2005 Jul;58(1):94-9
pubmed: 15901894
Pediatr Infect Dis J. 1996 Sep;15(9):841
pubmed: 8878238
Am J Perinatol. 1996 Jan;13(1):35-6
pubmed: 8645383
BMC Infect Dis. 2015 Feb 06;15:46
pubmed: 25656597
Afr J Reprod Health. 2013 Sep;17(3):160-8
pubmed: 24069778
Can Fam Physician. 2015 Oct;61(10):875-6
pubmed: 26759844
Pediatr Dev Pathol. 2009 May-Jun;12(3):249-52
pubmed: 19140638
JAMA. 2018 Jun 12;319(22):2333-2335
pubmed: 29896619
Clin Infect Dis. 1996 Feb;22(2):336-40
pubmed: 8838193
J Reprod Med. 1981 Jun;26(6):317-9
pubmed: 7252951
J Hum Lact. 1997 Dec;13(4):307-11
pubmed: 9429366
J Antimicrob Chemother. 2015 Jan;70(1):14-22
pubmed: 25204341
Med Mycol. 2012 Jul;50(5):543-8
pubmed: 22103347
Br Med J. 1973 Nov 10;4(5888):337-8
pubmed: 4202261
Breastfeed Rev. 2011 Nov;19(3):25-9
pubmed: 22263374
Br J Obstet Gynaecol. 1998 Aug;105(8):882-9
pubmed: 9746382
Med J Aust. 1972 Oct 28;2(18):1005-7
pubmed: 4578877
BMC Infect Dis. 2016 Oct 19;16(1):582
pubmed: 27756232
N Engl J Med. 2018 Mar 15;378(11):1004-1017
pubmed: 29539274
Lancet. 2015 May 30;385(9983):2173-82
pubmed: 25765698
Anat Rec. 1954 Sep;120(1):33-63
pubmed: 13207763
Obstet Gynecol. 1983 Sep;62(3 Suppl):35s-37s
pubmed: 6877708
Br J Clin Pharmacol. 1999 Aug;48(2):234-8
pubmed: 10417502
AIDS. 2012 Jul 17;26(11):1363-70
pubmed: 22526517
Am J Obstet Gynecol. 1996 Dec;175(6):1645-50
pubmed: 8987954
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
N Engl J Med. 1992 Mar 19;326(12):793-8
pubmed: 1538722
PLoS One. 2017 May 22;12(5):e0177093
pubmed: 28531175
Obstet Gynecol. 1999 Nov;94(5 Pt 2):850
pubmed: 10546761
Clin Infect Dis. 2010 Feb 1;50(3):338-44
pubmed: 20038244
PLoS One. 2019 Jan 10;14(1):e0210105
pubmed: 30629619
Arch Pathol Lab Med. 1994 Jul;118(7):757-9
pubmed: 8024415
Hum Pathol. 1989 Sep;20(9):920-1
pubmed: 2777245
Clin Infect Dis. 2010 Jun 1;50(11):1532-8
pubmed: 20415574
AIDS. 2013 Nov 13;27(17):2787-97
pubmed: 24056068
J Perinatol. 2012 Mar;32(3):235-7
pubmed: 22370896
Br J Radiol. 2008 Feb;81(962):e53-6
pubmed: 18238916

Auteurs

Katelyn A Pastick (KA)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Elizabeth Nalintya (E)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Lillian Tugume (L)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Kenneth Ssebambulidde (K)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Nicole Stephens (N)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Emily E Evans (EE)

Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

Jane Frances Ndyetukira (JF)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Edwin Nuwagira (E)

Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

Caleb Skipper (C)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Conrad Muzoora (C)

Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

David B Meya (DB)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Joshua Rhein (J)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

David R Boulware (DR)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Radha Rajasingham (R)

Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH